Loading clinical trials...
Loading clinical trials...
Salavge Chemotherapy With Cladribine, Cytarabine and Mitoxantrone Followed by Mobilized Peripheral Stem Cell Infusion From the Original Donor for Relapsed Patients After Allogeneic Stem Cell Transplantation: Phase I/II Study
Conditions
Interventions
CLAM+PBSC
Locations
1
China
Rui Jin Hospital, Department of Hematology
Shanghai, China
Start Date
September 1, 2016
Primary Completion Date
September 1, 2023
Completion Date
September 1, 2023
Last Updated
November 26, 2021
NCT06311227
NCT00106925
NCT06285890
NCT07388563
NCT06852222
NCT06220162
Lead Sponsor
Shanghai Jiao Tong University School of Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions